Guangzhou Pluslife Biotech Co., Ltd.

Private

GuangzhouHealthcare & Life Scienceshttps://pluslife.com/

Last Round

Series B

Nov 19, 2025

Total Funding Raised

$37.56M

Company Overview

Guangzhou Pluslife Biotech Co., Ltd. is a biotechnology company that specializes in the research, development, and manufacturing of advanced molecular point-of-care testing diagnostic systems.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

point-of-care diagnosticsPOC diagnosticsmolecular diagnosticsnucleic acid testingisothermal amplificationportable diagnostic devicediagnostic reagent kitsinfectious disease testingrapid testingmedical devicedecentralized testingrazor-and-blades modelclinical laboratory equipmentmultiplex testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Guangzhou Pluslife Biotech Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Guangzhou Pluslife Biotech Co., Ltd. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Guangzhou Pluslife Biotech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Nov 19, 2025
Grant	Oct 1, 2025
Grant	Nov 1, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Xiaofan Zeng

CFO

Executive Team

Guangzhou Pluslife Biotech Co., Ltd. Investors

Notable investors and investment history

Guangzhou Pluslife Biotech Co., Ltd. investors
Investor	Rounds
Gates Foundation	Grant
Puhua Capital	Series B
Qiming Venture Partners	Series B
Guangzhou Guoju Venture Capital	Series B

View all Investors

Guangzhou Pluslife Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Guangzhou Pluslife Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Guangzhou Pluslife Biotech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersGuangzhou

Employee Range44

Year Founded2017

Last FundingNov 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.